TickerFactsScreenerDevelopers

Xeris Biopharma Holdings, Inc. (XERS) — Revenue

Annual figures by fiscal year, from SEC filings.

2020: $20.16M2021: $49.59M2022: $110.25M2023: $163.91M2024: $203.07M2025: $291.85M$291.85M
2020Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$291.85M+43.7%
2024$203.07M+23.9%
2023$163.91M+48.7%
2022$110.25M+122.3%
2021$49.59M+146.0%
2020$20.16M—